epithelial ovarian cancer

You have access
Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
SIMON DUCOULOMBIER, FRANÇOIS GOLFIER, OLIVIER COLOMBAN, DAVID BENAYOUN, PIERRE-ADRIEN BOLZE, MICHEL TOD and BENOIT YOU

Anticancer Research December 2017, 37 (12) 6879-6886;
You have access
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research
ANGIOLO GADDUCCI and MARIA ELENA GUERRIERI

Anticancer Research November 2017, 37 (11) 5955-5965;
You have access
Response of OVCAR-3 Cells to Cisplatin and Hyperthermia: Does Hyperthermia Really Matter?
ARTURAS SUKOVAS, VAIDOTAS CESNA, ALDONA JASUKAITIENE, GIEDRIUS BARAUSKAS, RUTA JOLANTA NADISAUSKIENE, ZILVINAS DAMBRAUSKAS, SAULIUS PASKAUSKAS and ANTANAS GULBINAS

Anticancer Research September 2017, 37 (9) 5011-5018;
You have access
Impact of Open Laparoscopy in Patients Under Suspicion of Ovarian Cancer
LARS SCHRÖDER, CHRISTIAN RUDLOWSKI, PAULA KUTKUHN, ALINA ABRAMIAN, CHRISTINA KAISER, WALTHER CHRISTIAN KUHN and MIGNON-DENISE KEYVER-PAIK

Anticancer Research July 2016, 36 (7) 3459-3464;
You have access
PARP Inhibitors in Epithelial Ovarian Cancer: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and MARIA ELENA GUERRIERI

Anticancer Research May 2016, 36 (5) 2055-2064;
You have access
Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity
AURÉLIE PELISSIER, CLAIRE BONNEAU, ELISABETH CHÉREAU, THIBAULT DE LA MOTTE ROUGE, VIRGINIE FOURCHOTTE, EMILE DARAÏ and ROMAN ROUZIER

Anticancer Research April 2016, 36 (4) 1865-1871;
You have access
Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience
NICOLAE BACALBASA, SIMONA DIMA, IRINA BALESCU, LEONARD DAVID, VLADISLAV BRASOVEANU and IRINEL POPESCU

Anticancer Research July 2015, 35 (7) 4099-4104;
You have access
The Role of Quaternary Cytoreduction in Recurrent Epithelial Ovarian Cancer: A Single-center Experience
NICOLAE BACALBAŞA, IRINA BALESCU, SIMONA DIMA, VLADISLAV BRASOVEANU and IRINEL POPESCU

Anticancer Research June 2015, 35 (6) 3519-3523;
You have access
Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer
GUN OH CHONG, HYO-SUNG JEON, HYUNG SOO HAN, JI WOONG SON, YOON HEE LEE, DAE GY HONG, YOON SOON LEE and YOUNG LAE CHO

Anticancer Research May 2015, 35 (5) 2611-2617;
You have access
Advanced Epithelial Ovarian Cancer: From Standard Chemotherapy to Promising Molecular Pathway Targets – Where Are we Now?
JOHN SYRIOS, SUSANA BANERJEE and STANLEY B. KAYE

Anticancer Research May 2014, 34 (5) 2069-2077;

Main menu

User menu

Search

epithelial ovarian cancer

Pages